Christine Desbiens1, Myriam Filion2, Marie-Chantale Brien3, Jean-Charles Hogue4, Christian Laflamme4, Julie Lemieux5. 1. Centre de recherche du CHU de Québec - Université Laval, Hôpital du Saint-Sacrement, 1050 Chemin Sainte-Foy, Québec, QC G1S 4L8, Canada; Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, CHU de Québec - Université Laval, 1050 Chemin Sainte-Foy, Québec, QC G1S 4L8, Canada; Département de Chirurgie, Faculté de médecine, Université Laval, Pavillon Ferdinand-Vandry, 1050 Avenue de la Médecine, Québec, QC G1V 0A6, Canada. 2. Centre de recherche du CHU de Québec - Université Laval, Hôpital du Saint-Sacrement, 1050 Chemin Sainte-Foy, Québec, QC G1S 4L8, Canada; Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, CHU de Québec - Université Laval, 1050 Chemin Sainte-Foy, Québec, QC G1S 4L8, Canada; Département de médecine Sociale et préventive, Faculté de médecine, Université Laval, Pavillon Ferdinand-Vandry, 1050 Avenue de la Médecine, Québec, QC G1V 0A6, Canada. 3. Centre de recherche du CHU de Québec - Université Laval, Hôpital du Saint-Sacrement, 1050 Chemin Sainte-Foy, Québec, QC G1S 4L8, Canada; Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, CHU de Québec - Université Laval, 1050 Chemin Sainte-Foy, Québec, QC G1S 4L8, Canada; Département de médecine, Faculté de médecine, Université Laval, Pavillon Ferdinand-Vandry, 1050 Avenue de la Médecine, Québec, QC G1V 0A6, Canada. 4. Centre de recherche du CHU de Québec - Université Laval, Hôpital du Saint-Sacrement, 1050 Chemin Sainte-Foy, Québec, QC G1S 4L8, Canada; Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, CHU de Québec - Université Laval, 1050 Chemin Sainte-Foy, Québec, QC G1S 4L8, Canada. 5. Centre de recherche du CHU de Québec - Université Laval, Hôpital du Saint-Sacrement, 1050 Chemin Sainte-Foy, Québec, QC G1S 4L8, Canada; Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, CHU de Québec - Université Laval, 1050 Chemin Sainte-Foy, Québec, QC G1S 4L8, Canada; Centre Universitaire d'hématologie et d'oncologie de Québec, CHU de Québec - Université Laval, Québec, QC, Canada; Département de médecine, Faculté de médecine, Université Laval, Pavillon Ferdinand-Vandry, 1050 Avenue de la Médecine, Québec, QC G1V 0A6, Canada. Electronic address: julie.lemieux@crchudequebec.ulaval.ca.
Abstract
BACKGROUND:Physical activity improves the quality of life of cancer survivors, but whether there is a difference between individual vs. group physical activity is unknown. OBJECTIVES: To compare fatigue at 12 weeks in breast cancer survivors after participation in a program of group vs. individual video-assisted physical activity. METHODS: This was a randomized phase II pilot study carried out in breast cancer survivors at a tertiary breast cancer center. Eligible patients were randomized to individual or group 12-week physical activity program. The primary outcome was fatigue (FACT-F). Aerobic capacity (6-min walk test), muscular strength, and quality-of-life (FACT-G and FACT-B) were assessed. Because of poor accrual, 200 consecutive breast cancer patients were surveyed about their physical activity habits to assess reasons for low recruitment. RESULTS:For all participants (n = 26; n = 12 for group vs. n = 14 for individual), there were some improvement in FACT-F, FACT-G, FACT-B, physical activity level, aerobic capacity, and shoulder strength. Among the 200 patients surveyed, 58% were interested to increase their physical activity level, 15% declared that they were already exercising enough, 9% declared being unable to, 3% declared having no time, and 2% declared having no interest, and other reasons (13%). Among the 200 patients surveyed, 25% preferred in group, 57% preferred alone, and 18% had no preference. CONCLUSION: Low recruitment precluded conclusions about the efficacy of physical activity practiced in group vs. individually, but both groups derived a benefit. Low willingness to change exercising habits could be the biggest barrier to physical activity in breast cancer survivors.
RCT Entities:
BACKGROUND: Physical activity improves the quality of life of cancer survivors, but whether there is a difference between individual vs. group physical activity is unknown. OBJECTIVES: To compare fatigue at 12 weeks in breast cancer survivors after participation in a program of group vs. individual video-assisted physical activity. METHODS: This was a randomized phase II pilot study carried out in breast cancer survivors at a tertiary breast cancer center. Eligible patients were randomized to individual or group 12-week physical activity program. The primary outcome was fatigue (FACT-F). Aerobic capacity (6-min walk test), muscular strength, and quality-of-life (FACT-G and FACT-B) were assessed. Because of poor accrual, 200 consecutive breast cancerpatients were surveyed about their physical activity habits to assess reasons for low recruitment. RESULTS: For all participants (n = 26; n = 12 for group vs. n = 14 for individual), there were some improvement in FACT-F, FACT-G, FACT-B, physical activity level, aerobic capacity, and shoulder strength. Among the 200 patients surveyed, 58% were interested to increase their physical activity level, 15% declared that they were already exercising enough, 9% declared being unable to, 3% declared having no time, and 2% declared having no interest, and other reasons (13%). Among the 200 patients surveyed, 25% preferred in group, 57% preferred alone, and 18% had no preference. CONCLUSION: Low recruitment precluded conclusions about the efficacy of physical activity practiced in group vs. individually, but both groups derived a benefit. Low willingness to change exercising habits could be the biggest barrier to physical activity in breast cancer survivors.
Authors: Erica Nicole Reed; Jessa Landmann; Devesh Oberoi; Katherine-Ann L Piedalue; Peter Faris; Linda E Carlson Journal: Evid Based Complement Alternat Med Date: 2020-04-13 Impact factor: 2.629
Authors: Cynthia C Forbes; Flavia Swan; Sarah L Greenley; Michael Lind; Miriam J Johnson Journal: J Cancer Surviv Date: 2020-04-24 Impact factor: 4.442